转录因子IRF-4通过AhR介导巨噬细胞持续M2极化并促进IRI-AKI后肾脏纤维化的机制研究

批准号:
81970575
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
李志莲
依托单位:
学科分类:
泌尿系统损伤与修复
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
李志莲
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
缺血再灌注肾损伤(IRI-AKI)修复期肾脏巨噬细胞(M)持续朝M2极化,引起细胞外基质堆积是肾脏纤维化的关键机制之一。干扰素调节因子(IRF)4是调控M2极化的重要转录因子。我们的前期工作发现,敲除巨噬细胞 IRF4可减轻IRI-AKI后M2极化并减轻肾纤维化。IRF4如何调控M2极化?进一步,我们观察到M敲除IRF4可阻断芳香烃受体(AhR)转录,而AhR本身是调节免疫细胞分化的重要转录因子,生物信息学分析其启动子存在可能结合IRF4的序列。因此,我们提出IRF4可能通过增强AhR转录,从而介导M2极化促进肾脏纤维化的假说。本项目拟在巨噬细胞敲除AhR的小鼠IRI-AKI模型中研究IRF4/AhR对M2极化的作用;进一步在体外采用ChIP和基因突变技术,研究IRF4和AhR启动子的相互作用。这些工作将揭示IRI-AKI修复期M2持续极化的调控机制,为防治肾纤维化提供新的思路和治疗靶点。
英文摘要
Severe ischemia-reperfusion associated acute kidney injury (IRI-AKI) leads to renal fibrosis , in which sustained alternative activated macrophage(M2) polarization plays a pivotal role during the late repair phase of severe AKI by producing sustained TGF-beta and extracellular matrix components, and subsequently contributes to renal fibrosis. Interferon regulatory factor 4 (IRF4) is an important transcriptional factor that regulates M2. Our recent preliminary data showed that macrophage-specific knockout (KO) IRF4 reduced M2 polarization and thus alleviated renal fibrosis. Our findings suggest IRF4 promotes kidney fibrogenesis, but how? We further observed that IRF4 decreased the transcription of Aryl hydrocarbon receptor (AhR, another important transcriptional factor for immune cells) and its downstream target genes. Bio-informatics analysis from GENECARDS bank indicates there is IRF4-binding sequence in AhR’s promotor domain. Therefore, we raise the hypothesis that IRF4 may mediate sustained M2 polarization via AhR on renal fibrosis following ischemic reperfusion kidney injury. In this proposal, macrophage specific deletion of AhR mice are used to establish IRI-AKI model to investigate the role of AhR in M2 polarization and renal fibrosis. To further explore the relationship between IRF4 and AhR, IL4/IL13 stimulation were used to induce M2 in vitro, and we use ChIP and gene mutation to demonstrate their binding sequence. Our study will provide significant insight into the mechanism by which IRF4 promotes renal fibrosis after IRI-AKI. Manipulation of IRF4 might be a novel approach for the prevent and treatment of renal fibrosis.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
RIP3 impedes transcription factor EB to suppress autophagic degradation in septic acute kidney injury.
RIP3 阻碍转录因子 EB,从而抑制脓毒症急性肾损伤中的自噬降解。
DOI:10.1038/s41419-021-03865-8
发表时间:2021-06-08
期刊:Cell death & disease
影响因子:9
作者:Li R;Zhao X;Zhang S;Dong W;Zhang L;Chen Y;Li Z;Yang H;Huang Y;Xie Z;Wang W;Li C;Ye Z;Dong Z;Liang X
通讯作者:Liang X
DOI:10.3969/j.issn.1671-2390.m20-258
发表时间:2021
期刊:临床肾脏病杂志
影响因子:--
作者:校振萌;李志莲;董伟;张梦希;陈源汉;李锐钊;梁馨苓
通讯作者:梁馨苓
The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study
共存糖尿病对特发性膜性肾病患者临床结局的影响:一项回顾性观察研究
DOI:10.1186/s12882-020-01878-7
发表时间:2019-09
期刊:BMC Nephrology
影响因子:2.3
作者:Xie Zhiyong;Li Zhilian;Dong Wei;Chen Yuanhan;Li Ruizhao;Wu Yanhua;Liang Huaban;Ye Zhiming;Liu Shuangxin;Shi Wei;Liang Xinling
通讯作者:Liang Xinling
Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study.
代谢综合征和合并糖尿病与原发性肾小球疾病患者心血管合并症的较高风险相关:一项回顾性观察研究
DOI:10.1002/clc.23388
发表时间:2020-09
期刊:Clinical cardiology
影响因子:2.7
作者:Xie Z;Li Z;Dong W;Chen Y;Li R;Wu Y;Lin T;Tao Y;Liang H;Wang W;Liu S;Ye Z;Shi W;Liang X
通讯作者:Liang X
DOI:10.3760/cma.j.cn441217-20220930-00156
发表时间:2022
期刊:中华肾脏病杂志
影响因子:--
作者:李志莲;付欣怡;蔡文菁;雷陈瑜;白晓燕;叶智明
通讯作者:叶智明
Pim-3促进自噬对脓毒血症所致肾小管上皮细胞损伤的保护作用
- 批准号:81200544
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2012
- 负责人:李志莲
- 依托单位:
国内基金
海外基金
